MAZE Maze Therapeutics, Inc. - Common Stock
$25,36
Preço · Mai 20, 2026
Fundamentais a partir de Mai 12, 2026
Intervalo 52 Semanas
$9–$54
36% of range
Classificação do Analista
BUY
12 analysts
Preço-Alvo
$63
+148% upside
P/E (TTM)
-13.6
ROE
-598.9%
Margem de Lucro Líquido
—
MAZE Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$25.36
Capitalização de Mercado
$2.04B
P/E (TTM)
-13.6
EPS (TTM)
$-3.05
Receita (TTM)
$168M
Rendimento div.
—
ROE
-598.9%
Dívida/Capital
—
Intervalo 52 Semanas
$9 – $54
MAZE Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$168M
2024-12-31
→
2024-12-31
EPS
$-3.05
2024-12-31
→
2025-12-31
Fluxo de caixa livre
$-113M
2025-12-31
→
2025-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
MAZE
Mediana de Pares
P/E (TTM)
-13.6
22.4
P/B
5.8
4.6
Price / FCF (Preço / FCF)
-18.1
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
MAZE
Mediana de Pares
ROA
-41.1%
-7.1%
ROE
-598.9%
-18.6%
ROIC
-40.3%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
MAZE
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
15.5
3.9
Quick Ratio (Índice de Liquidez Seca)
15.2
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
MAZE
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
MAZE
Mediana de Pares
MAZE Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
12 analistas
- Compra forte 5 41,7%
- Compra 6 50,0%
- Manter 1 8,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
11 analistas · 2026-05-16
Mediana
$56.00
Média
$63.00
← Abaixo de todos os alvos
$25.36
Mín
$46.00
Máx
$110.00
Alvo mediano
$56.00
+120,8%
Alvo médio
$63.00
+148,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-3.1%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.45 | $-0.56 | 0.11% |
| 31 de Dezembro de 2025 | $-0.65 | $-0.73 | 0.08% |
| 30 de Setembro de 2025 | $-0.66 | $-0.72 | 0.06% |
| 30 de Junho de 2025 | $-0.77 | $-0.87 | 0.10% |
| 31 de Março de 2025 | $-1.15 | $-0.77 | -0.38% |
| 31 de Dezembro de 2024 | $-18.32 | $0.46 | -18.8% |
Comparação com pares Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | — |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 13
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $168M | |
| R&D Expense | $108M | $83M | |
| SG&A Expense | $34M | $26M | |
| Operating Expenses | $143M | $110M | |
| Operating Income | $-143M | $58M | |
| Pretax Income | $-131M | $53M | |
| Income Tax | $0 | $1M | |
| Net Income | $-131M | $52M | |
| EPS (Basic) | $-3.05 | $1.42 | |
| EPS (Diluted) | $-3.05 | $1.25 | |
| Shares (Basic) | 42,976,024 | 2,396,094 | |
| Shares (Diluted) | 42,976,024 | 2,730,299 | |
| EBITDA | $-143M | · |
Balanço Patrimonial 20
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $197M | |
| Short-term Investments | $153M | · | |
| Prepaid Expense | $8M | $5M | |
| Current Assets | $350M | $202M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $24M | $24M | |
| Accum. Depreciation | $19M | $17M | |
| Other Non-current Assets | $3M | $8M | |
| Total Assets | $397M | $241M | |
| Accounts Payable | $2M | $2M | |
| Current Liabilities | $23M | $21M | |
| Capital Leases | $19M | $22M | |
| Other Non-current Liabilities | $1M | $969.0K | |
| Total Liabilities | $42M | $44M | |
| Common Stock | $49.0K | $2.0K | |
| Paid-in Capital | $844M | $47M | |
| Retained Earnings | $-490M | $-358M | |
| Stockholders' Equity | $355M | $-311M | |
| Liabilities + Equity | $397M | $241M | |
| Shares Outstanding | 49,335,551 | 2,446,864 |
Fluxo de Caixa 7
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $16M | $10M | |
| Operating Cash Flow | $-112M | $76M | |
| CapEx | $794.0K | $1M | |
| Investing Cash Flow | $-171M | $-1M | |
| Financing Cash Flow | $275M | $93M | |
| Taxes Paid | · | $1M | |
| Free Cash Flow | $-113M | · |
Lucratividade 3
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| ROA | -41.1% | · | |
| ROE | -598.9% | · | |
| ROIC | -40.3% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 15.5 | · | |
| Quick Ratio | 15.2 | · |
Avaliação (TTM) 9
| Métrica | Tendência | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $168M | |
| Net Income TTM | $-131M | $52M | |
| Market Cap | $2.04B | · | |
| P/E | -13.6 | · | |
| P/B | 5.8 | · | |
| P / Tangible Book | 5.8 | · | |
| P / Cash Flow | -18.3 | · | |
| P / FCF | -18.1 | · | |
| Earnings Yield | -7.4% | · |
Demonstração de Resultados 14
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | · | · | $0 | · | $0 | $165M | |
| R&D Expense | $34M | $28M | $25M | $28M | $28M | $22M | $20M | |
| SG&A Expense | $12M | $10M | $8M | $8M | $8M | $8M | $6M | |
| Operating Expenses | $47M | $38M | $33M | $36M | $35M | $30M | $25M | |
| Operating Income | $-27M | $-38M | $-33M | $-36M | $-35M | $-30M | $140M | |
| Other Non-op | $2M | · | · | · | $3M | · | · | |
| Pretax Income | · | $-35M | $-30M | $-34M | $-33M | $-30M | $141M | |
| Income Tax | · | $0 | $0 | $0 | · | $-275.0K | $2M | |
| Net Income | $-24M | $-35M | $-30M | $-34M | $-33M | $-30M | $139M | |
| EPS (Basic) | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $19.66 | $5.92 | |
| EPS (Diluted) | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $22.19 | $3.22 | |
| Shares (Basic) | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -4,745,535 | 2,389,119 | |
| Shares (Diluted) | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -6,336,570 | 4,314,359 | |
| EBITDA | $-27M | · | $-33M | $-36M | $-35M | · | · |
Balanço Patrimonial 23
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $199M | $189M | $317M | $265M | $294M | $197M | · | |
| Short-term Investments | $154M | $153M | $67M | · | · | · | · | |
| Receivables | $20M | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $8M | $7M | $7M | $5M | $5M | · | |
| Current Assets | $380M | $350M | $391M | $271M | $300M | $202M | · | |
| PP&E (Net) | $5M | $5M | $6M | $6M | $6M | $7M | · | |
| PP&E (Gross) | · | $24M | · | · | · | $24M | · | |
| Accum. Depreciation | · | $19M | · | · | · | $17M | · | |
| Other Non-current Assets | $4M | $3M | $3M | $4M | $3M | $8M | · | |
| Total Assets | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Accounts Payable | $4M | $2M | $3M | $4M | $2M | $2M | · | |
| Current Liabilities | $21M | $23M | $22M | $20M | $19M | $21M | · | |
| Capital Leases | $18M | $19M | $19M | $20M | $21M | $22M | · | |
| Other Non-current Liabilities | $388.0K | $1M | $1M | $1M | $1M | $969.0K | · | |
| Total Liabilities | $78M | $42M | $43M | $41M | $41M | $44M | · | |
| Long-term Debt | $39M | · | · | · | · | · | · | |
| Total Debt | $39M | · | · | · | · | · | · | |
| Common Stock | $50.0K | $49.0K | $48.0K | $44.0K | $44.0K | $2.0K | · | |
| Paid-in Capital | $856M | $844M | $834M | $687M | $683M | $47M | · | |
| Retained Earnings | $-514M | $-490M | $-455M | $-425M | $-391M | $-358M | · | |
| Stockholders' Equity | $342M | $355M | $379M | $262M | $292M | $-311M | · | |
| Liabilities + Equity | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Shares Outstanding | 49,737,619 | 49,335,551 | 48,076,885 | 43,850,884 | 43,797,166 | 2,446,864 | · |
Fluxo de Caixa 7
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $6M | $4M | $3M | $3M | $3M | $2M | |
| Operating Cash Flow | $-39M | $-28M | $-25M | $-30M | $-30M | $-22M | $145M | |
| CapEx | $93.0K | $34.0K | $68.0K | $393.0K | $299.0K | $605.0K | $160.0K | |
| Investing Cash Flow | $6M | $-103M | $-67M | $-393.0K | $-299.0K | $-605.0K | $-160.0K | |
| Financing Cash Flow | $42M | $4M | $144M | $612.0K | $127M | $70M | $154.0K | |
| Taxes Paid | · | · | · | · | · | $0 | · | |
| Free Cash Flow | $-39M | · | · | · | $-30M | · | · |
Lucratividade 6
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132.8% | · | · | · | · | · | · | |
| Net Margin | -121.0% | · | · | · | · | · | · | |
| EBITDA Margin | -132.8% | · | · | · | · | · | · | |
| ROA | -6.4% | · | -14.3% | -22.2% | -19.7% | · | · | |
| ROE | -7.6% | · | -15.9% | -25.7% | -22.4% | · | · | |
| ROIC | · | · | -8.7% | -13.9% | · | · | · |
Liquidez e Solvência 4
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.9 | · | 17.7 | 13.6 | 16.1 | · | · | |
| Quick Ratio | 17.5 | · | 17.4 | 13.3 | 15.8 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · |
Eficiência 2
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.0 | · | · | · | |
| Receivables Turnover | 2.0 | · | · | · | · | · | · |
Avaliação (TTM) 11
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | · | $-121M | $48M | $49M | · | · | |
| Market Cap | $1.48B | · | $1.25B | $538M | $482M | · | · | |
| Enterprise Value | $1.17B | · | · | · | · | · | · | |
| P/E | -9.9 | · | -2.0 | -1.4 | -0.5 | · | · | |
| P/B | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Tangible Book | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Cash Flow | -38.0 | · | · | · | -16.3 | · | · | |
| P / FCF | -37.9 | · | · | · | -16.2 | · | · | |
| EV / EBITDA | -44.1 | · | · | · | · | · | · | |
| EV / FCF | -29.9 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | · | -49.5% | -72.9% | -200.6% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Receita | — | $168M |
| Lucro líquido | $-131M | $52M |
| EPS Diluído | $-3.05 | $1.25 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Índice de liquidez corrente | 15.5 | — |
| Índice de Liquidez Seca | 15.2 | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Fluxo de caixa livre | $-113M | — |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.